Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand (212)Pb-NG001

SIMPLE SUMMARY: Prostate-specific membrane antigen (PSMA) is a protein overexpressed in metastatic castration-resistant prostate cancer and a promising target for targeted radionuclide therapy. PSMA-targeted alpha therapy is of growing interest due to the high-emission energy and short range of alph...

Descripción completa

Detalles Bibliográficos
Autores principales: Stenberg, Vilde Yuli, Tornes, Anna Julie Kjøl, Nilsen, Hogne Røed, Revheim, Mona-Elisabeth, Bruland, Øyvind Sverre, Larsen, Roy Hartvig, Juzeniene, Asta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179904/
https://www.ncbi.nlm.nih.gov/pubmed/35681766
http://dx.doi.org/10.3390/cancers14112784

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179904/
https://www.ncbi.nlm.nih.gov/pubmed/35681766
http://dx.doi.org/10.3390/cancers14112784

Ejemplares similares